ADRB2 and cancer: High levels of β2AR have been reported in human cell lines [11,23,24] and tumour samples [25] and importantly, we have shown that cell migration in a number of cancer models is inhibited by the beta-blocker adrenergic receptor antagonist, propranolol [11,12,14].